Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.38
-0.1200-8.00%
Post-market: 1.400.0200+1.45%17:05 EDT
Volume:717.21K
Turnover:1.03M
Market Cap:99.29M
PE:-0.44
High:1.54
Open:1.47
Low:1.37
Close:1.50
Loading ...

Zentalis Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
1 hour ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Jun

Zentalis Pharmaceuticals Inc. to Present at Jefferies Healthcare Conference in New York

Reuters
·
20 May

Zentalis Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
15 May

Zentalis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

Benzinga
·
15 May

BRIEF-Zentalis Pharmaceuticals Q1 Operating Expenses USD 45.623 Million

Reuters
·
15 May

Zentalis Pharmaceuticals Inc -$332.5 Mln Cash Supporting Operations Into Late 2027

THOMSON REUTERS
·
15 May

Zentalis Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
02 May

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 May

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

Simply Wall St.
·
29 Apr

Zentalis Pharmaceuticals Inc - Topline Data From Denali Part 2 Expected by Year End 2026

THOMSON REUTERS
·
28 Apr

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

GlobeNewswire
·
28 Apr

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

GlobeNewswire
·
24 Apr

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
02 Apr

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 Apr

Promising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals

TIPRANKS
·
01 Apr

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

TIPRANKS
·
31 Mar

Guggenheim Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
30 Mar

Zentalis Pharmaceuticals Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
28 Mar